Alessandro Buda1,2, Federica Elisei3, Sharon Palazzi4, Elena De Ponti5, Maurizio Arosio3, Francesca Vecchione6, Tiziana Dell'Anna6, Marco Cuzzocrea4, Beatrice Bussi4, Daniela Giuliani4, Giampaolo Di Martino4, Cinzia Crivellaro3,7. 1. Gynecologic Oncology Surgery Unit, Department of Obstetrics and Gynecology, San Gerardo Hospital, Monza, Italy. ginoncmonza@gmail.com. 2. University of Milano-Bicocca, Monza, Italy. ginoncmonza@gmail.com. 3. Department of Nuclear Medicine, San Gerardo Hospital, Monza, Italy. 4. University of Milano-Bicocca, Monza, Italy. 5. Department of Medical Physics, San Gerardo Hospital, Monza, Italy. 6. Gynecologic Oncology Surgery Unit, Department of Obstetrics and Gynecology, San Gerardo Hospital, Monza, Italy. 7. Technomed Foundation, University of Milano-Bicocca, Monza, Italy.
Abstract
OBJECTIVES: The purpose of this study was to assess the quality of care in patients who underwent sentinel lymph node (SLN) mapping for endometrial and cervical cancer staging, and evaluate the impact of different techniques on patient satisfaction, i.e. radiotracer Tc99m versus indocyanine green (ICG) or methylene blue injection. METHOD: Women with preoperative stage I endometrial cancer or stage I (1A2-1B1) cervical cancer who underwent surgical staging, including SLN mapping, were considered for this study. Patient satisfaction was assessed using the European Organisation for Research and Treatment of Cancer IN-PATSAT32 questionnaire. Women were classified into two groups according to the different nodal mapping techniques: intracervical preoperative injection of Tc99m nanocolloid + intraoperative blue dye (Group 1) versus intraoperative cervical injection of ICG or blue dye (Group 2). Differences in patient satisfaction scores between the groups were analyzed. RESULTS: Of the 178 eligible women, 143 were included in the study (endometrial cancer n = 106, cervical cancer n = 37): 57 underwent SLN mapping with Tc99m and blue dye (Group 1), and 86 women were mapped intraoperatively with blue dye alone or ICG (Group 2). Analysis of IN-PATSAT32 questionnaire scores showed a higher patient satisfaction score for patients in Group 2 (p = 0.001), which was independent of the physician and surgical outcomes evaluated. The scores were statistically better for Group 2, and also in rating doctors (p = 0.0001), nurses (p = 0.006), and care and services organizations (p = 0.001). CONCLUSIONS: Cervical and endometrial cancer patients who underwent SLN mapping by ICG or blue dye perceived a better quality of care when compared with those patients who underwent the combined radiocolloid and blue dye technique.
OBJECTIVES: The purpose of this study was to assess the quality of care in patients who underwent sentinel lymph node (SLN) mapping for endometrial and cervical cancer staging, and evaluate the impact of different techniques on patient satisfaction, i.e. radiotracer Tc99m versus indocyanine green (ICG) or methylene blue injection. METHOD:Women with preoperative stage I endometrial cancer or stage I (1A2-1B1) cervical cancer who underwent surgical staging, including SLN mapping, were considered for this study. Patient satisfaction was assessed using the European Organisation for Research and Treatment of Cancer IN-PATSAT32 questionnaire. Women were classified into two groups according to the different nodal mapping techniques: intracervical preoperative injection of Tc99m nanocolloid + intraoperative blue dye (Group 1) versus intraoperative cervical injection of ICG or blue dye (Group 2). Differences in patient satisfaction scores between the groups were analyzed. RESULTS: Of the 178 eligible women, 143 were included in the study (endometrial cancer n = 106, cervical cancer n = 37): 57 underwent SLN mapping with Tc99m and blue dye (Group 1), and 86 women were mapped intraoperatively with blue dye alone or ICG (Group 2). Analysis of IN-PATSAT32 questionnaire scores showed a higher patient satisfaction score for patients in Group 2 (p = 0.001), which was independent of the physician and surgical outcomes evaluated. The scores were statistically better for Group 2, and also in rating doctors (p = 0.0001), nurses (p = 0.006), and care and services organizations (p = 0.001). CONCLUSIONS: Cervical and endometrial cancerpatients who underwent SLN mapping by ICG or blue dye perceived a better quality of care when compared with those patients who underwent the combined radiocolloid and blue dye technique.
Authors: Andrea Papadia; Maria Luisa Gasparri; Alessandro Buda; Michael D Mueller Journal: J Cancer Res Clin Oncol Date: 2017-08-21 Impact factor: 4.553
Authors: Andrea Papadia; Ignacio Zapardiel; Beatrice Bussi; Fabio Ghezzi; Marcello Ceccaroni; Elena De Ponti; Federica Elisei; Sara Imboden; Begoña Diaz de la Noval; Maria Luisa Gasparri; Giampaolo Di Martino; Javier De Santiago; Michael Mueller; Francesca Vecchione; Federica Dell'Orto; Alessandro Buda Journal: J Cancer Res Clin Oncol Date: 2016-11-03 Impact factor: 4.553
Authors: Thomas Papathemelis; Anton Scharl; Michael Anapolski; Elisabeth C Inwald; Atanas Ignatov; Olaf Ortmann; Michael Gerken; Monika Klinkhammer-Schalke; Sophia Scharl Journal: Arch Gynecol Obstet Date: 2020-02-11 Impact factor: 2.493